Heart failure hospitalization2
34%Reduction in heart failure hospitalization at 1-year post-implant in patients already optimized on GDMT.
2. The effect of CCM® Therapy on hospitalization has not been evaluated by the US FDA and has not been studied in RCTs.
Events per patient-year
−34.0% · p=0.039| Time period | Events | Patient-years | Event rate |
|---|---|---|---|
| Pre-CCM, 1 year (n=338) | 152 | 338.0 | 0.45 |
| Post-CCM, 1 year (n=338) | 91 | 306.8 | 0.30 |


CCM® Therapy
530
Feb 2020 – Jun 2026